These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9117569)

  • 1. Cellular aspects of the inflammatory response in Alzheimer's disease.
    Kalaria RN; Cohen DL; Premkumar DR
    Neurodegeneration; 1996 Dec; 5(4):497-503. PubMed ID: 9117569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microglia and Alzheimer's disease.
    Kalaria RN
    Curr Opin Hematol; 1999 Jan; 6(1):15-24. PubMed ID: 9915549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microglia in Alzheimer's disease: the good, the bad and the ugly.
    Tejera D; Heneka MT
    Curr Alzheimer Res; 2016; 13(4):370-80. PubMed ID: 26567746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer's disease.
    Cai Z; Hussain MD; Yan LJ
    Int J Neurosci; 2014 May; 124(5):307-21. PubMed ID: 23930978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular aspects of inflammatory and immune responses in Alzheimer's disease.
    Kalaria RN; Harshbarger-Kelly M; Cohen DL; Premkumar DR
    Neurobiol Aging; 1996; 17(5):687-93. PubMed ID: 8892341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal influence of microglial activation and amyloid on neuronal function in Alzheimer's disease.
    Fan Z; Okello AA; Brooks DJ; Edison P
    Brain; 2015 Dec; 138(Pt 12):3685-98. PubMed ID: 26510952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloid differentiation factor 88-deficient bone marrow cells improve Alzheimer's disease-related symptoms and pathology.
    Hao W; Liu Y; Liu S; Walter S; Grimm MO; Kiliaan AJ; Penke B; Hartmann T; Rübe CE; Menger MD; Fassbender K
    Brain; 2011 Jan; 134(Pt 1):278-92. PubMed ID: 21115468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-amyloid precursor protein transgenic mice that harbor diffuse A beta deposits but do not form plaques show increased ischemic vulnerability: role of inflammation.
    Koistinaho M; Kettunen MI; Goldsteins G; Keinänen R; Salminen A; Ort M; Bures J; Liu D; Kauppinen RA; Higgins LS; Koistinaho J
    Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1610-5. PubMed ID: 11818564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microglial interaction with beta-amyloid: implications for the pathogenesis of Alzheimer's disease.
    Bamberger ME; Landreth GE
    Microsc Res Tech; 2001 Jul; 54(2):59-70. PubMed ID: 11455613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the toll-like receptor 4 in neuroinflammation in Alzheimer's disease.
    Walter S; Letiembre M; Liu Y; Heine H; Penke B; Hao W; Bode B; Manietta N; Walter J; Schulz-Schuffer W; Fassbender K
    Cell Physiol Biochem; 2007; 20(6):947-56. PubMed ID: 17982277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immunopathology of Alzheimer's disease and some related disorders.
    Kalaria RN
    Brain Pathol; 1993 Oct; 3(4):333-47. PubMed ID: 8293190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How chronic inflammation can affect the brain and support the development of Alzheimer's disease in old age: the role of microglia and astrocytes.
    Blasko I; Stampfer-Kountchev M; Robatscher P; Veerhuis R; Eikelenboom P; Grubeck-Loebenstein B
    Aging Cell; 2004 Aug; 3(4):169-76. PubMed ID: 15268750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of complement and activated microglia in the pathogenesis of Alzheimer's disease.
    Eikelenboom P; Veerhuis R
    Neurobiol Aging; 1996; 17(5):673-80. PubMed ID: 8892339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active immunization against complement factor C5a: a new therapeutic approach for Alzheimer's disease.
    Landlinger C; Oberleitner L; Gruber P; Noiges B; Yatsyk K; Santic R; Mandler M; Staffler G
    J Neuroinflammation; 2015 Aug; 12():150. PubMed ID: 26275910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphologically distinct types of amyloid plaques point the way to a better understanding of Alzheimer's disease pathogenesis.
    D'Andrea MR; Nagele RG
    Biotech Histochem; 2010 Apr; 85(2):133-47. PubMed ID: 20121465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Environmental Enrichment Potently Prevents Microglia-Mediated Neuroinflammation by Human Amyloid β-Protein Oligomers.
    Xu H; Gelyana E; Rajsombath M; Yang T; Li S; Selkoe D
    J Neurosci; 2016 Aug; 36(35):9041-56. PubMed ID: 27581448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resting microglia react to Aβ42 fibrils but do not detect oligomers or oligomer-induced neuronal damage.
    Ferrera D; Mazzaro N; Canale C; Gasparini L
    Neurobiol Aging; 2014 Nov; 35(11):2444-2457. PubMed ID: 24973120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroinflammation in Alzheimer's disease: an understanding of physiology and pathology.
    Obulesu M; Jhansilakshmi M
    Int J Neurosci; 2014 Apr; 124(4):227-35. PubMed ID: 23919560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innate immune system and inflammation in Alzheimer's disease: from pathogenesis to treatment.
    Serpente M; Bonsi R; Scarpini E; Galimberti D
    Neuroimmunomodulation; 2014; 21(2-3):79-87. PubMed ID: 24557039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroinflammation in Alzheimer's disease and Parkinson's disease: are microglia pathogenic in either disorder?
    Rogers J; Mastroeni D; Leonard B; Joyce J; Grover A
    Int Rev Neurobiol; 2007; 82():235-46. PubMed ID: 17678964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.